MIDWEST BIOMEDICAL ACCELERATOR CONSORTIUM (MBARC)
Missouri-Columbia, the Midwest Biomedical Accelerator Consortium (MBArC) is an NIH Research Evaluation and Commercialization Hub (REACH) program with a goal to provide funding, training, and education to academic researchers to accelerate the transition of discoveries originating from research labs into products that improve health. P
MIDWEST BIOMEDICAL ACCELERATOR CONSORTIUM (MBARC)
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Nginx ReCAPTCHA COVID-19 ReCAPTCHA V2 Typekit Vimeo New Relic
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-23 | BioFluidica | Midwest Biomedical Accelerator Consortium (MBArC) investment in Grant - BioFluidica | N/A |
| 2021-08-12 | BioFluidica | Midwest Biomedical Accelerator Consortium (MBArC) investment in Grant - BioFluidica | 25 K USD |